The clinical use of blood based biomarkers

A webinar by Dr. Aurélien Lathuilière, University Hospital of Geneva
Blood-based biomarkers are emerging as a major addition to the Alzheimer's disease diagnostic toolkit and plasma p-tau217 is now the most validated candidate. It tracks Alzheimer's pathology with accuracy approaching CSF and PET, from a simple blood draw.
This talk uses p-tau217 as a case study in translating a biomarker into clinical practice: its diagnostic performance, unresolved questions around assay variability, cutoff validation and confounders. We discuss its emerging roles, in triage, differential diagnosis, treatment eligibility and as well as the key challenges that must be resolved before broader clinical use.
The webinar is hosted by (University of Zurich) and offers a platform for shared learning and discussion, enabling participants to exchange insights and experiences.
Event details:
- Date: 08.10.2026
- Time: 12:00
- Duration: 50 minutes (includes Q&A)
- Location: Online (link to be provided upon registration)
- Costs: Free of charge
Credits
- Schweizerische Vereinigung für Neuropsychologie (SVNP): 1 credit
- Schweizerische Fachgesellschaft für Geriatrie (SFGG): 1 credit
- Schweizerische Neurologische Gesellschaft (SNG): 1 credit
Secure your spot
Fill out the registration form below and you will receive a link to access the webinar.
About the speaker
Dr. Aurélien Lathuilière is featured on our community platform’s expert list. Visit his profile to explore his research interests, ongoing projects, publications, and potential collaboration opportunities.

Dementia Update - Clinical Series
Developed with the Swiss Memory Clinics for clinicians and healthcare professionals working in dementia care, each session addresses a key clinical topic and includes an interactive discussion with Q&A. The series promotes knowledge exchange across and within clinical disciplines and is hosted by a representative of the Swiss Memory Clinics.